RecallDepth
Class III Terminated

Relpax (eletriptan HBr) 40 mg, a) 12 tablets 2 cards x six 40 mg tablets per blister pack, NDC 0049-2340-05; b) 6 tablets 1 card x six 40 mg tablets per blister pack, NDC 0049-2340-45, Rx Only, Made in Ireland, Distributed by Roerig, Division of Pfizer Inc, NY NY 10017.

Company
Pfizer Inc.
Recall Initiated
April 29, 2019
Posted
May 22, 2019
Recall Number
D-1278-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
100277 tablets
Firm Location
New York, NY, United States

Reason for Recall

Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #s: a) W38322, Exp 10/2020, W98482, Exp 03/2021; b) W64062, Exp 01/2021, X27517, Exp 03/2021, AJ3674, Exp 11/2021.

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls